GQG · Class I · 21 CFR 866.3480

FDA Product Code GQG: Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus

Leading manufacturers include Nano-Ditech Corporation and Hangzhou Clongene Biotech Co., Ltd..

32
Total
32
Cleared
105d
Avg days
1977
Since
Growing category - 2 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 151d recently vs 102d historically

FDA 510(k) Cleared Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus Devices (Product Code GQG)

32 devices
1–24 of 32

About Product Code GQG - Regulatory Context

510(k) Submission Activity

32 total 510(k) submissions under product code GQG since 1977, with 32 receiving FDA clearance (average review time: 105 days).

Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under GQG have taken an average of 151 days to reach a decision - up from 102 days historically. Manufacturers should account for longer review timelines in current project planning.

GQG devices are reviewed by the Microbiology panel. Browse all Microbiology devices →